Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$37.11 - $50.69 $27,053 - $36,953
729 Added 5.01%
15,285 $735,000
Q1 2024

Apr 15, 2024

BUY
$40.65 - $65.76 $591,701 - $957,202
14,556 New
14,556 $698,000
Q1 2022

Apr 26, 2022

SELL
$64.92 - $99.47 $23,695 - $36,306
-365 Closed
0 $0
Q4 2021

Jan 13, 2022

BUY
$76.51 - $93.96 $9,181 - $11,275
120 Added 48.98%
365 $33,000
Q3 2021

Oct 18, 2021

BUY
$71.29 - $95.99 $17,466 - $23,517
245 New
245 $20,000
Q2 2021

Jul 30, 2021

SELL
$79.62 - $114.85 $614,029 - $885,723
-7,712 Closed
0 $0
Q1 2021

Apr 20, 2021

BUY
$77.91 - $125.92 $600,841 - $971,095
7,712 New
7,712 $825,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.96B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.